Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia.
作者信息
Bergwitz Clemens, Collins Michael T, Kamath Ravi S, Rosenberg Andrew E
机构信息
Division of Endocrinology, Massachusetts General Hospital, and Department of Medicine, Harvard Medical School, Boston, USA.
出版信息
N Engl J Med. 2011 Oct 27;365(17):1625-35. doi: 10.1056/NEJMcpc1104567.
Abstract
摘要
相似文献
1
Case records of the Massachusetts General Hospital. Case 33-2011. A 56-year-old man with hypophosphatemia.马萨诸塞州总医院病例记录。病例33 - 2011。一名56岁的低磷血症男性。
N Engl J Med. 2011 Oct 27;365(17):1625-35. doi: 10.1056/NEJMcpc1104567.
2
Tumor-induced Osteomalacia in a 3-Year-Old With Unresectable Central Giant Cell Lesions.一名3岁患有不可切除的中央巨细胞病变患者的肿瘤性骨软化症
J Pediatr Hematol Oncol. 2017 Jan;39(1):e21-e24. doi: 10.1097/MPH.0000000000000686.
3
[Tumor-induced hypophosphatemic osteomalacia].肿瘤诱导的低磷性骨软化症
Nihon Naika Gakkai Zasshi. 2007 Apr 10;96(4):731-6. doi: 10.2169/naika.96.731.
4
Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.肿瘤相关性骨软化症治愈性手术后的低磷血症和重症监护时间延长：一例报告。
Front Endocrinol (Lausanne). 2021 Jun 3;12:686135. doi: 10.3389/fendo.2021.686135. eCollection 2021.
5
Tumor-induced osteomalacia.肿瘤诱导的骨软化症。
JAMA. 2005 Sep 14;294(10):1260-7. doi: 10.1001/jama.294.10.1260.
6
[Tumor-induced rickets/osteomalacia].肿瘤诱导的佝偻病/骨软化症
Nihon Rinsho. 2006 Jun 28;Suppl 2:96-9.
7
Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.成纤维细胞生长因子23的体静脉采样在识别肿瘤性骨软化症相关肿瘤中的临床应用
J Intern Med. 2010 Oct;268(4):390-4. doi: 10.1111/j.1365-2796.2010.02262.x.
8
Intracranial phosphaturic mesenchymal tumors. A case report and review of literature.颅内磷酸盐尿性间叶性肿瘤。病例报告及文献复习。
Neuropathology. 2022 Oct;42(5):453-458. doi: 10.1111/neup.12817. Epub 2022 Jul 26.
9
Radiofrequency ablation in tumour-induced osteomalacia: a therapeutic challenge.肿瘤诱导的骨软化症中的射频消融：一项治疗挑战。
BMJ Case Rep. 2025 Jan 14;18(1):e262528. doi: 10.1136/bcr-2024-262528.
10
The Game Is Afoot.游戏开始了。
N Engl J Med. 2020 May 28;382(22):e78. doi: 10.1056/NEJMimc1914302.
引用本文的文献
1
Adult-onset hypophosphatemic osteomalacia as a cause of widespread musculoskeletal pain: A retrospective case series of single center experience.成人迟发性低磷性骨软化症作为广泛肌肉骨骼疼痛的病因：一项单中心经验的回顾性病例系列研究
World J Clin Cases. 2023 Nov 16;11(32):7785-7794. doi: 10.12998/wjcc.v11.i32.7785.
2
Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia.英菲格拉替尼可降低肿瘤诱导的骨软化症中纤维母细胞生长因子23（FGF23）水平并提高血磷水平。
JBMR Plus. 2022 Jul 22;6(8):e10661. doi: 10.1002/jbm4.10661. eCollection 2022 Aug.
3
Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series.肿瘤性骨软化症中的持续性和复发性：文献系统综述及全国调查/病例系列研究结果。
Endocrine. 2022 Jun;76(3):709-721. doi: 10.1007/s12020-022-03039-2. Epub 2022 Apr 5.
4
Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms.下颌骨造釉细胞瘤性纤维牙源性肿瘤致肿瘤诱导性骨软化症：88 例磷酸尿性口腔肿瘤病例回顾。
Head Neck Pathol. 2021 Sep;15(3):975-988. doi: 10.1007/s12105-020-01267-4. Epub 2021 Jan 4.
5
Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia.靶向成纤维细胞生长因子受体阻断剂治疗肿瘤诱导的骨软化症
N Engl J Med. 2020 Oct 1;383(14):1387-1389. doi: 10.1056/NEJMc2020399. Epub 2020 Sep 9.
6
Tumor-Induced Osteomalacia.肿瘤相关性骨软化症。
Calcif Tissue Int. 2021 Jan;108(1):128-142. doi: 10.1007/s00223-020-00691-6. Epub 2020 Jun 5.
7
Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors.颌骨磷酸酶性间叶性肿瘤的临床、组织病理学、亚型及免疫组化分析
Medicine (Baltimore). 2020 Feb;99(7):e19090. doi: 10.1097/MD.0000000000019090.
8
[Hypophosphatemic osteomalacia caused by urinary mesenchymal tumor: A case report].[尿间充质肿瘤所致低磷性骨软化症：一例报告]
Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Dec 18;51(6):1169-1172. doi: 10.19723/j.issn.1671-167X.2019.06.034.
9
Tumor induced osteomalacia in head and neck region: single center experience and systematic review.头颈部肿瘤诱导的骨软化症：单中心经验及系统评价
Endocr Connect. 2019 Oct;8(10):1330-1353. doi: 10.1530/EC-19-0341.
10
Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review.颌骨中同时含有上皮和间叶成分的磷酸盐尿基质肿瘤：22 例临床病理和免疫组织化学分析并文献复习
Mod Pathol. 2019 Feb;32(2):189-204. doi: 10.1038/s41379-018-0100-0. Epub 2018 Sep 11.
本文引用的文献
1
Selective venous catheterization for the localization of phosphaturic mesenchymal tumors.选择性静脉导管术用于定位磷酸化解质肿瘤。
J Bone Miner Res. 2011 Jun;26(6):1295-302. doi: 10.1002/jbmr.316.
2
Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.甲状旁腺激素、维生素 D 和 FGF23 对磷酸盐稳态的调节。
Annu Rev Med. 2010;61:91-104. doi: 10.1146/annurev.med.051308.111339.
3
Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia.抗 FGF23 抗体在低磷血症性佝偻病/骨软化症中的治疗作用。
J Bone Miner Res. 2009 Nov;24(11):1879-88. doi: 10.1359/jbmr.090509.
4
Type IIc sodium-dependent phosphate transporter regulates calcium metabolism.IIc型钠依赖性磷酸盐转运体调节钙代谢。
J Am Soc Nephrol. 2009 Jan;20(1):104-13. doi: 10.1681/ASN.2008020177. Epub 2008 Dec 3.
5
Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma?klotho与钠钾ATP酶活性：能否解决钙代谢难题？
Nephrol Dial Transplant. 2008 Feb;23(2):459-61. doi: 10.1093/ndt/gfm702. Epub 2007 Oct 31.
6
Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro.成纤维细胞生长因子23在体内损害磷和维生素D代谢，并在体外抑制25-羟基维生素D-1α-羟化酶表达。
Am J Physiol Renal Physiol. 2007 Nov;293(5):F1577-83. doi: 10.1152/ajprenal.00463.2006. Epub 2007 Aug 15.
7
Radiofrequency ablation of a tumor causing oncogenic osteomalacia.对导致致癌性骨软化症的肿瘤进行射频消融。
N Engl J Med. 2007 Jul 26;357(4):422-4. doi: 10.1056/NEJMc070347.
8
Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.成纤维细胞生长因子23在慢性肾脏病磷稳态及矿物质代谢紊乱发病机制中的作用
Semin Dial. 2007 Jul-Aug;20(4):302-8. doi: 10.1111/j.1525-139X.2007.00308.x.
9
PET/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia.导致肿瘤性骨软化症的磷尿性间叶肿瘤的PET/CT定位
Clin Nucl Med. 2007 Apr;32(4):300-1. doi: 10.1097/01.rlu.0000257180.03964.51.
10
Cinacalcet in the management of tumor-induced osteomalacia.西那卡塞在肿瘤诱导性骨软化症治疗中的应用
J Bone Miner Res. 2007 Jun;22(6):931-7. doi: 10.1359/jbmr.070304.
Zotero 插件